Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TGF-β: the master regulator of fibrosis
Xiao‐Ming Meng, David J. Nikolic‐Paterson, Hui Y. Lan
Nature Reviews Nephrology (2016) Vol. 12, Iss. 6, pp. 325-338
Closed Access | Times Cited: 2794

Showing 1-25 of 2794 citing articles:

Mechanisms of Renal Fibrosis
Benjamin D. Humphreys
Annual Review of Physiology (2017) Vol. 80, Iss. 1, pp. 309-326
Open Access | Times Cited: 940
New insights into TGF-β/Smad signaling in tissue fibrosis
He-He Hu, Dan‐Qian Chen, Yanni Wang, et al.
Chemico-Biological Interactions (2018) Vol. 292, pp. 76-83
Open Access | Times Cited: 900
Macrophages: versatile players in renal inflammation and fibrosis
Patrick Ming‐Kuen Tang, David J. Nikolic‐Paterson, Hui Y. Lan
Nature Reviews Nephrology (2019) Vol. 15, Iss. 3, pp. 144-158
Closed Access | Times Cited: 758
Fibroblast-specific TGF-β–Smad2/3 signaling underlies cardiac fibrosis
Hadi Khalil, Onur Kanisicak, Vikram Prasad, et al.
Journal of Clinical Investigation (2017) Vol. 127, Iss. 10, pp. 3770-3783
Open Access | Times Cited: 742
Targeting the progression of chronic kidney disease
Marta Ruíz-Ortega, Sandra Rayego‐Mateos, Santiago Lamas, et al.
Nature Reviews Nephrology (2020) Vol. 16, Iss. 5, pp. 269-288
Closed Access | Times Cited: 703
Contextual determinants of TGFβ action in development, immunity and cancer
Charles J. David, Joan Massagué
Nature Reviews Molecular Cell Biology (2018) Vol. 19, Iss. 7, pp. 419-435
Open Access | Times Cited: 689
Renal tubule injury: a driving force toward chronic kidney disease
Bi‐Cheng Liu, Tao‐Tao Tang, Lin‐Li Lv, et al.
Kidney International (2018) Vol. 93, Iss. 3, pp. 568-579
Open Access | Times Cited: 681
Targeting TGF-β signal transduction for fibrosis and cancer therapy
Dandan Peng, Minyang Fu, Manni Wang, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 584
Targeting integrin pathways: mechanisms and advances in therapy
Xiaocong Pang, He Xu, Zhiwei Qiu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 487
Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis
Kelly L. Walton, Katharine E. Johnson, Craig A. Harrison
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 469
Epigenetics and epigenomics in diabetic kidney disease and metabolic memory
Mitsuo Kato, Rama Natarajan
Nature Reviews Nephrology (2019) Vol. 15, Iss. 6, pp. 327-345
Open Access | Times Cited: 450
Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology
Neel I. Nissen, M.A. Karsdal, Nicholas Willumsen
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 405
Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors
Ralph A. DeFronzo, William Reeves, Alaa S. Awad
Nature Reviews Nephrology (2021) Vol. 17, Iss. 5, pp. 319-334
Closed Access | Times Cited: 397
Cellular and molecular mechanisms of kidney fibrosis
Sonja Djudjaj, Peter Boor
Molecular Aspects of Medicine (2018) Vol. 65, pp. 16-36
Closed Access | Times Cited: 382
TGF-β orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1
Jie Su, Sophie M. Morgani, Charles J. David, et al.
Nature (2020) Vol. 577, Iss. 7791, pp. 566-571
Open Access | Times Cited: 375
TGF-β1 – A truly transforming growth factor in fibrosis and immunity
Monika Lodyga, Boris Hinz
Seminars in Cell and Developmental Biology (2019) Vol. 101, pp. 123-139
Closed Access | Times Cited: 362
Cytokine signature associated with disease severity in chronic fatigue syndrome patients
José G. Montoya, Tyson H. Holmes, Jill N. Anderson, et al.
Proceedings of the National Academy of Sciences (2017) Vol. 114, Iss. 34
Open Access | Times Cited: 347
Fibroblasts in the Infarcted, Remodeling, and Failing Heart
Claudio Humeres, Nikolaos G. Frangogiannis
JACC Basic to Translational Science (2019) Vol. 4, Iss. 3, pp. 449-467
Open Access | Times Cited: 324
PD-1 up-regulation on CD4 + T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production
Lindsay J. Celada, Jonathan A. Kropski, José D. Herazo-Maya, et al.
Science Translational Medicine (2018) Vol. 10, Iss. 460
Open Access | Times Cited: 297
Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment
Lin Chen, Tian Yang, Dewen Lu, et al.
Biomedicine & Pharmacotherapy (2018) Vol. 101, pp. 670-681
Open Access | Times Cited: 296
TGF-β and the Tissue Microenvironment: Relevance in Fibrosis and Cancer
Laia Caja, Francesco Dituri, Serena Mancarella, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 5, pp. 1294-1294
Open Access | Times Cited: 285
Inflammation and renal fibrosis: Recent developments on key signaling molecules as potential therapeutic targets
Wenshan Lv, George W. Booz, Yangang Wang, et al.
European Journal of Pharmacology (2017) Vol. 820, pp. 65-76
Open Access | Times Cited: 273
Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy
Yangfu Jiang, Hongying Zhang, Jiao Wang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 270
Inflammatory macrophages can transdifferentiate into myofibroblasts during renal fibrosis
Xiao‐Ming Meng, Shuang Wang, Xiao-Ru Huang, et al.
Cell Death and Disease (2016) Vol. 7, Iss. 12, pp. e2495-e2495
Open Access | Times Cited: 268
Targeting fibrosis: mechanisms and clinical trials
Manyu Zhao, Liqun Wang, Mengzhu Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 258
Page 1 - Next Page

Scroll to top